Recent U.S. Customs and Border Protection rulings from CROSS, searchable by HTS code, keyword, or ruling number.
In your letter dated September 9, 2026, you requested a tariff classification ruling. Norepinephrine Bitartrate, imported in 4 mg/4 mL vials, is a vasopressor indicated to raise blood pressure in adult patients with severe, acute hypotension and as an adjunct treatment during cardiac arrest. In your letter, you stated the country of origin of Norepinephrine Bitartrate is Italy and exported from India.
In your letter dated August 21, 2026, you requested a tariff classification ruling. Fulvestrant Injection, imported in 250 mg/5 mL syringes, is an estrogen receptor antagonist. It is indicated for the treatment of hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy.
In your letter dated August 21, 2026, you requested a tariff classification ruling. Fulvestrant Injection, imported in 250 mg/5 mL syringes, is an estrogen receptor antagonist. It is indicated for the treatment of hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy.
In your letter dated July 8, 2026, you requested a tariff classification ruling. Progesterone, imported in 100 mg and 200 mg capsules, is in a class of medications called progestins. It is indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. It is also indicated for use in secondary amenorrhea. In your letter, you stated the country of origin is China and exported out of India.
Source: rulings.cbp.gov (CROSS). This index holds New York rulings from the recent period and the Headquarters rulings they cite. It is not the full CROSS database of 222,467 rulings, and it does not hold every Headquarters ruling. New rulings usually appear here within a few days of CBP publishing them; a ruling published long after its number was assigned can take several weeks. A ruling is marked revoked or modified only when an indexed Headquarters ruling says so, so the absence of a mark is not confirmation that a ruling is still in effect. A ruling letter is binding on CBP only for the particular transaction or issue it describes (19 CFR 177.9). Confirm the text and status on CROSS before relying on a ruling. Not legal advice.